ACM
IBB icon

Aster Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Aster Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.41M Buy
18,851
+11,641
+161% +$1.99M 0.79% 30
2025
Q4 		$1.22M Sell
7,210
-6,000
-45% -$975K 0.53% 30
2025
Q3 		$1.91M Buy
+13,210
New +$1.8M 0.96% 14

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Aster Capital Management's IBB Position: Q1 2026 in Review

Aster Capital Management increased its iShares Biotechnology ETF (IBB) stake by 161% in Q1 2026, buying an estimated $1.99M and bringing the position to 18,851 shares worth $2.41M. The position accounts for 0.79% of the portfolio, ranked #30.

Aster Capital Management first reported a position in IBB in Q3 2025 and has held it in 3 quarters since. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Aster Capital Management held 18,851 shares of iShares Biotechnology ETF worth $2.41M as of Q1 2026.
  • Aster Capital Management bought 11,641 iShares Biotechnology ETF shares in Q1 2026, an estimated $1.99M.
  • iShares Biotechnology ETF made up 0.79% of Aster Capital Management's portfolio in Q1 2026, its #30 holding.
  • Aster Capital Management first reported a position in iShares Biotechnology ETF in Q3 2025 and has held it in 3 quarters since.
  • 919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.